Please assess the completion status of the following clinical trial:

Trial Title: Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* confirmed (within last 3 months)progressive Stage IV NSCLC~* estimated life span of 3 months~* phase angle of at least 5 as measured by bioimpedance~Exclusion Criteria:~* currently taking a lipid lowering medications~* has an imminently life threatening condition~* has pre-existing liver disease~* known allergy to soybeans~* uncontrolled diabetes or uncontrolled disturbance of lipid metabolism~* pregnant or lactating~* has a pacemaker or other implantable electronic medical device

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Kanglaite injection (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).